INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 435m ago
HOUSE PTR35m ago
SEC 13F35m ago
ROBINHOOD CHAIN34m ago
Public company

LBRXLB PHARMACEUTICALS INC

CIK 0001691082

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score9
Connections6with evidence

LBRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KG
Kozauer Susan GaniChief Medical Officer
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
200.0K sh
Oct 9, 2026Oct 13, 2026
traded Oct 9, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Kozauer Susan GaniChief Medical Officer · Oct 13, 2026
  • ← Insider ofevidence
    Miller Joseph MChief Financial Officer · Oct 13, 2026
  • ← Insider ofevidence
    Luse RebeccaDirector · Jun 5, 2026
9
MM
Miller Joseph MChief Financial Officer
LBRXLB PHARMACEUTICALS INC
Grant or award
A
—
200.0K sh
Oct 9, 2026
Oct 13, 2026
traded Oct 9, 2026
+4d
SEC FORM 4

Evidence

9
LR
Luse RebeccaDirector
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
10.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
12.5K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
20.0K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

9
PK
Pai Panandiker Kaya KamleshChief Commercial Officer
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
195.0K sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Lenz Robert A.Director · Mar 10, 2026
  • ← Insider ofevidence
    Pai Panandiker Kaya KamleshChief Commercial Officer · Dec 11, 2025